Abstract
Weight gain is a reported problem associated with adjuvant chemotherapy for breast cancer and often generates psychosocial stress in women [1]. It also may affect prognosis and survival. Changes in body composition and weight during chemotherapy, particularly adjuvant treatment of breast carcinoma, have been previously reported [1–3]. Multiple reasons for this weight gain have been suggested though few theories have been scientifically validated [4].
The aim of this study was to investigate body composition and its relationship to weight change associated with the CMF‐based breast cancer chemotherapy protocols. Total body nitrogen (TBN), body fat, total body water (TBW), and anthropometric measurements were conducted on 25 female out‐patients (median age 47, range 26–70 years) receiving adjuvant CMF‐based chemotherapy for breast cancer. Total body nitrogen was measured using the In Vivo Neutron Capture Analysis (IVNCA) technique (on day 1 of cycles 2–6) and TBP was calculated by multiplying TBN by 6.25 [5]. Nitrogen Index (NI) was calculated by expressing TBN as a percentage of normal.
There was a significant increase in mean body weight during chemotherapy of 2.35 kg (p<0.0001). Serial measurements showed no significant change in mean TBN, NI, or percentage body fat. Break down of body weight showed a significant increase in mean TBW of 0.79 kg (p=0.003) and mean fat mass of 1.49 kg (p=0.008).
We conclude that weight gain observed during adjuvant chemotherapy for breast carcinoma is primarily due to an increase in fat and TBW.
Similar content being viewed by others
References
Heasman KZ, Sutherland HJ, Campbell JA, Elhakim T, Boyd NF: Weight gain during adjuvant chemotherapy for breast cancer. Breast Cancer Res Treat 5: 195–200, 1985
Macfie J, Burkinshaw L: Body composition in malignant disease. Metabolism 36: 290–294, 1987
Huntington MO: Weight gain in patients receiving adjuvant chemotherapy for carcinoma of the breast. Cancer 56: 472–474, 1985
Demark-Wahnefried W, Winer EP, Rimer BK: Why women gain weight with adjuvant chemotherapy for breast cancer. J Clin Oncol 11: 1418–1429, 1993
Allen BJ, Blagojevic N, Delaney I, Pollock CA, Ibels LS, Allman MA, Tiller DJ, Gaskin KJ, Baur LA, Waters DL, Cowell CT, Ambler G, Quigley C, Fletcher JP: The role of body protein studies in clinical trials. Basic Life Sci 55: 155–169, 1990
Early Breast Cancer Trialists' Collaboration Group: World wide evidence: treatment of early breast cancer (1985-1990). Oxford Medical Publications, Oxford, 1990
Lindeman GJ, Boyages J, Driessen C, Langlands AO: Intravenous or oral adjuvant CMF for node-positive breast cancer. Aust NZ J Surg 62: 556–562, 1992
Brincker H, Mouridsen HT, Andersen KW: Adjuvant chemotherapy with cyclophosphamide or CMF in premenopausal women with stage II breast cancer. Breast Cancer Res Treat 3: 91–95, 1983
Wood WC, Weiss RB, Tormey DC, Holland JF, Henry PH, Leone LA, Rafla S, Silver RT, Carey RW, Lesnick GJ, et al.: A randomized trial of CMF versus CMFVP as adjuvant chemotherapy in women with node-positive stage II breast cancer: a CALGB Study. World J Surg 9: 714–718, 1985
Tancini G, Bonadonna G, Valagussa P, Marchini S, Veronesi U: Adjuvant CMF in breast cancer: comparative 5-year results of 12 versus 6 cycles. J Clin Oncol 1: 2–10, 1983
Bonadonna G, Brusamolino E, Valagussa P, Rossi A, Brugnatelli L, Brambilla C, De Lena M, Tancini G, Bajetta E, Musumeci R, Veronesi U: Combination chemotherapy as an adjuvant treatment in operable breast cancer. N Engl J Med 294: 405–410, 1976
Goodwin PJ, Panzarella T, Boyd NF: Weight gain in women with localized breast cancer-a descriptive study. Breast Cancer Res Treat 11: 59–66, 1988
Camoriano JK, Loprinzi CL, Ingle JN, Therneau TM, Krook JE, Veeder MH: Weight change in women treated with adjuvant therapy or observed following mastectomy for nodepositive breast cancer. J Clin Oncol 8: 1327–1334, 1990
Cheney CL, Mahloch J, Freeny P: Computerized tomography assessment of women with weight changes associated with adjuvant treatment for breast cancer. Am J Clin Nutr 66: 141–146, 1997
Aslani A, Smith RC, Allen BJ, Levi JA: Changes in body composition during adjuvant chemotherapy for breast cancer. Appl Radiat Isot 49: 637–638, 1998
Durnin JV, Rahaman MM: The assessment of the amount of fat in the human body from measurements of skinfold thickness. Br J Nutr 21: 681–689, 1967
Durnin JV, Womersley J: Total body fat, calculated from body density, and its relationship to skinfold thickness in 571 people aged 12-72 years. Proc Nutr Soc 32: 45A, 1973
Durnin JV, Armstrong WH, Womersley J: An experimental study on the variability of measurements of skinfold thicknesses by three observers on twenty-three young women and twenty-seven young men. Proc Nutr Soc 30: 9A–10A, 1971
Durnin JV, Womersley J: Body fat assessed from total body density and its estimation from skinfold thickness: measurements on 481 men and women aged from16 to 72 years. Br J Nutr 32: 77–97, 1974
Pollock CA, Ibels LS, Allen BJ, Ayass W, Caterson RJ, Waugh DA, Macadam C, Pennock Y, Mahony JF: Total body nitrogen as a prognostic marker in maintenance dialysis. J Am Soc Nephrol 6: 82–88, 1995
Allen BJ, Blagojevic N, McGregor BJ, Parsons DE, Gaskin KJ, Soutter VL, Waters DL, Allman MA, Stewart PJ, Tiller DJ: In vivo determination of protein in malnourished patients. In: Ellis KJ, Yasumura S, Morgan WD (eds) In vivo Body Composition Studies. Institute of Physical Sciences in Medicine, London, 1987, pp 77–82
Baur LA, Knight JF, Crawford BA, Reed E, Roy LP, Allen BJ, Gaskin KJ: Total body nitrogen in children with chronic renal failure and short stature. Eur J Clin Nutr 48: 433–441, 1994
Allen BJ, Bailey GM, McGregor BJ: Dose equivalent distributions in the AAEC total body nitrogen facility. In: Anonymous Proceedings of the Fourth Australian Conference on Nuclear Techniques of Analysis. AINSE, Sydney, 1985, pp. 168–170
Baur LA, Waters DL, Allen BJ, Blagojevic N, Gaskin KJ: Nitrogen deposition in malnourished children with cystic fibrosis. Am J Clin Nutr 53: 503–511, 1991
Vartsky D, Prestwich WV, Thomas BJ, Dabek JT, Chettle DR, Fremlin JH, Stammers K: The use of body hydrogen as an internal standard in the measurement of nitrogen in vivo by prompt neutron capture gamma-ray analysis. J Radioanal Chem 48: 243–252, 1979
Blagojevic N, Allen BJ, Gaskin KJ, Baur LA: Determination of total body water by Fourier transform infrared analysis. Australas Phys Eng Sci Med 13: 110–116, 1990
Bland JM, Altman DG: Statistical methods for assessing agreement between two methods of clinical measurement. Lancet Feb 8: 307–310, 1986
Cohn SH, Ellis KJ, Vartsky D, Sawitsky A, Gartenhaus W, Yasumura S, Vaswani AN: Comparison of methods of estimating body fat in normal subjects and cancer patients. Am J Clin Nutr 34: 2839–2847, 1981
Cohn SH, Gartenhaus W, Sawitsky A, Rai K, Zanzi I, Vaswani A, Ellis KJ, Yasumura S, Cortes E, Vartsky D: Compartmental body composition of cancer patients by measurement of total body nitrogen, potassium, and water. Metabolism 30: 222–229, 1981
Le Bricon T, Gugins S, Cynober L, Baracos VE: Negative impact of cancer chemotherapy on protein metabolism in healthy and tumor-bearing rats. Metabolism 44: 1340–1348, 1995
Harvey KB, Bothe A, Blackburn GL: Nutritional assessment and patient outcome during oncological therapy. Cancer 43: 2065–2069, 1979
Wilmore DW: Catabolic illness. Strategies for enhancing recovery. N Engl J Med 325: 695–702, 1991
Donaldson SS, Lenon RA: Alterations of nutritional status: impact of chemotherapy and radiation therapy. Cancer 43: 2036–2052, 1979
Levine EG, Raczynski JM, Carpenter JT: Weight gain with breast cancer adjuvant treatment. Cancer 67: 1954–1959, 1991
Kelsey JL: Breast cancer epidemiology: summary and future directions. Epidemiol Rev 15: 256–263, 1993
Schapira DV, Nagi BK, Lyman GH: Estimate of breast cancer risk reduction. Cancer 26: 2622–2625, 1991
Bonadonna G, Valagussa P, Rossi A, Tancini G, Brambilla C, Zambetti M, Veronesi U: Ten-year experience with CMFbased adjuvant chemotherapy in resectable breast cancer. Breast Cancer Res Treat 5: 95–115, 1985
Georgiadis MS, Steinberg SM, Hankins LA, Ihde DC, Johnson BE: Obesity and therapy-related toxicity in patients treated for small-cell lung cancer. J Natl Cancer Inst 87: 361–366, 1995
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Aslani, A., Smith, R., Allen, B. et al. Changes in body composition during breast cancer chemotherapy with the CMF‐regimen. Breast Cancer Res Treat 57, 285–290 (1999). https://doi.org/10.1023/A:1006220510597
Issue Date:
DOI: https://doi.org/10.1023/A:1006220510597